EnFUSiasm for Healing: Ultrasound Neuromodulation in PAH
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Rafikov R, Rischard F, Vasilyev M, Varghese M, Yuan J, Desai A
. Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex. Transl Res. 2022; 247:1-18.
PMC: 10062382.
DOI: 10.1016/j.trsl.2022.03.013.
View
2.
Shah A, Beckmann T, Vorla M, Kalra D
. New Drugs and Therapies in Pulmonary Arterial Hypertension. Int J Mol Sci. 2023; 24(6).
PMC: 10058689.
DOI: 10.3390/ijms24065850.
View
3.
Clements R, Vang A, Fernandez-Nicolas A, Kue N, Mancini T, Morrison A
. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan. Circ Heart Fail. 2019; 12(11):e005819.
PMC: 6857845.
DOI: 10.1161/CIRCHEARTFAILURE.119.005819.
View
4.
Rabinovitch M, Guignabert C, Humbert M, Nicolls M
. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014; 115(1):165-75.
PMC: 4097142.
DOI: 10.1161/CIRCRESAHA.113.301141.
View
5.
Kumar R, Graham B
. How does inflammation contribute to pulmonary hypertension?. Eur Respir J. 2018; 51(1).
PMC: 5973838.
DOI: 10.1183/13993003.02403-2017.
View